Invivoscribe Expands IVDR Portfolio with IdentiClone Dx IGH Assay Certification 2026-03-25T23:07:06-07:00March 25th, 2026|2026 Press Releases, Press Releases| Read more
Invivoscribe Launches LeukoStratKMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide 2026-02-05T14:09:13-08:00February 4th, 2026|2026 Press Releases, Press Releases| Read more